DrPH & DDS | Health IT, RWD/RWE, & Data Science Expert | Enhancing Healthcare by Bridging Clinician Needs with Tech Innovation
As the #pharma industry navigates the impact of the Inflation Reduction Act on drug pricing and #innovation; real-world evidence, propelled by the Cures Act, is becoming increasingly vital for driving strategy and drug development. I wanted to share this older paper we wrote before RWE became a thing, where we discuss the creation of a large real-world data asset focused on the neuroscience therapeutic area. #RealWorldData #RealWorldEvidence #InflationReducionAct #21CCA #CuresAct #DrugDevelopment #Pharmaceuticals #Neuroscience #DataScience #Innovation #BeforeItWasCool Regenstrief Institute, Inc. Brian E Dixon, PhD